Financhill
Back

Medifast Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
31

MED
Medifast

Last Price:
21.81
Seasonality Move:
44.33%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
41.06
Seasonality Move:
-0.9%
Sell
31
Medifast (MED) is a Sell

Is Medifast a Buy, Sell or Hold?

  • The current Medifast [MED] share price is $21.12. The Score for MED is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MED is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MED Stock Price Chart

What is Medifast's stock price today?

  • The Medifast share price today is $21.12
    The current trend is relatively stagnant and MED is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

MED Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.53 Sell
Relative Strength Index (14 RSI): 43.34 Sell
Chaikin Money Flow: 434288 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.86 - 24.12) Sell
Bollinger Bands (100): (23.05 - 42.21) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

MED Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.05 Buy
20-day SMA: 21.48 Sell
50-day SMA: 25.16 Sell
200-day SMA: 50.55 Sell
8-day EMA: 20.32 Buy
20-day EMA: 21.4 Sell
50-day EMA: 25.43 Sell
200-day EMA: 48.37 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

Medifast Earnings Growth & MED Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.68 per share, an increase next quarter of $1.06 per share, a decrease this year of $8.76 per share, and an increase next year of $1.13 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Medifast Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):